Right when it reported a 99 percent revenue jump, Malvern-based Neuronetics appointed Dan Reuvers, a medical device industry veteran, as its next CEO, writes John George for the Philadelphia Business Journal.
Reuvers will assume the top role at the medical technology company on March 23, succeeding Keith Sullivan, whose tenure started in July 2020. Sullivan revealed in November that he will be retiring as CEO effective June 30 and will stay on as a consultant to assist with the transition.
Reuvers previously led Minneapolis-based Tactile Medical as CEO, a company focused on home-based pneumatic compression devices for treating lymphedema and chronic swelling. Before that, he spent 12 years at Integra LifeSciences in multiple roles, including president of the Codman Specialty Surgical neurosurgery division.
Sullivan called Reuvers a proven leader with over three decades in the medical device industry.
“He knows how to build and scale commercial health care businesses,” he added.
Neuronetics, established in 2003, created the NeuroStar TMS Therapy System, employing magnetic pulses to treat depression by activating specific brain regions. The company’s revenue surged to $149.2 million last year from $74.9 million the previous year, driven by its December 2024 acquisition of Greenbrook TMS.
Read more about Neuronetics finding a new CEO in Dan Reuvers in the Philadelphia Business Journal.
______
Neuronetics’ NeuroStar TMS Therapy System.
